治疗多囊卵巢综合征中药专利申请现状分析OA

Objective To investigate the current status,research hotspots and development trends of global Chinese medicine patents for polycystic ovary syndrome(PCOS),and to provide patent data support for PCOS Chinese medicine research and development.Methods Patent data on Chinese medicine for treating PCOS from 2000 to 2025 were retrieved from the incoPat patent database.The trends in patent applications,geographical distribution,patent applicants,and technical efficacy and applications were collated and analyzed.Results A total of 550 patent families related to PCOS Chinese medicine were included.The main countries/regions/organizations for patent applications were China,the United States,and the World Intellectual Property Organization.In China,the main application regions involved Shandong,Jiangsu,Shanghai,Beijing,Guangdong and Heilongjiang.The main patent applicants were Heilongjiang University of Chinese Medicine(14 patents),HANALL BIOPHARMA CO.,LTD.(11 patents),and Kim Sung Wuk(10 patents).The patent technologies were mainly concentrated in the fields of A61K and A61P,with the technical efficacy primarily focusing on improving safety,alleviating symptoms,and reducing complexity.Conclusion Global PCOS Chinese medicine research and development is increasingly active,with precision and multi-technology integration being the core trends.The quality of patent applications needs to be further improved.